Back to dashboard
CommercialCoverageMedium impact

08.02.23, Tislelizumab-jsgr (Tevimbra®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Aug 25, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new pharmacy policy for Tislelizumab-jsgr (Tevimbra®) has been implemented for commercial plans. This policy establishes coverage and billing guidelines for this medication, which appears to be a newly covered pharmaceutical product.

Action Required

Action needed
By August 25, 2025: Billing team should review the complete policy details at the source URL to understand coverage criteria, prior authorization requirements, and billing procedures for Tislelizumab-jsgr (Tevimbra®). Update billing system and provider documentation as needed once full policy details are obtained.

Related policy hubs